Signal detection results for specific adverse events at the Preferred Term (PT) level.
<p>Signal detection results for specific adverse events at the Preferred Term (PT) level.</p>
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , |
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1852017370886832128 |
|---|---|
| author | Gang Ye (318792) |
| author2 | Luqin Ding (22110187) Qingbo Zhou (10832646) |
| author2_role | author author |
| author_facet | Gang Ye (318792) Luqin Ding (22110187) Qingbo Zhou (10832646) |
| author_role | author |
| dc.creator.none.fl_str_mv | Gang Ye (318792) Luqin Ding (22110187) Qingbo Zhou (10832646) |
| dc.date.none.fl_str_mv | 2025-08-22T17:25:02Z |
| dc.identifier.none.fl_str_mv | 10.1371/journal.pone.0330769.t003 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Signal_detection_results_for_specific_adverse_events_at_the_Preferred_Term_PT_level_/29968747 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biotechnology Immunology Cancer Science Policy Space Science Biological Sciences not elsewhere classified severe hypersensitivity reactions reporting odds ratio remained clinically significant proportional reporting ratio concurrent literature review adverse event profile serious adverse events remimazolam &# 8217 detected significant signals serious nature xlink "> study population study aimed strong signal ror ), risk patients risk groups remimazolam demonstrated predominantly elderly novel ultra less pronounced laryngeal edema including cardiac identified signals future research faers database faers data defined period clinical application cardiorespiratory arrest anaphylactic shock acting benzodiazepine |
| dc.title.none.fl_str_mv | Signal detection results for specific adverse events at the Preferred Term (PT) level. |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Signal detection results for specific adverse events at the Preferred Term (PT) level.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_bcfbb577ea5b830d90933cefdfcfee35 |
| identifier_str_mv | 10.1371/journal.pone.0330769.t003 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/29968747 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Signal detection results for specific adverse events at the Preferred Term (PT) level.Gang Ye (318792)Luqin Ding (22110187)Qingbo Zhou (10832646)BiotechnologyImmunologyCancerScience PolicySpace ScienceBiological Sciences not elsewhere classifiedsevere hypersensitivity reactionsreporting odds ratioremained clinically significantproportional reporting ratioconcurrent literature reviewadverse event profileserious adverse eventsremimazolam &# 8217detected significant signalsserious naturexlink ">study populationstudy aimedstrong signalror ),risk patientsrisk groupsremimazolam demonstratedpredominantly elderlynovel ultraless pronouncedlaryngeal edemaincluding cardiacidentified signalsfuture researchfaers databasefaers datadefined periodclinical applicationcardiorespiratory arrestanaphylactic shockacting benzodiazepine<p>Signal detection results for specific adverse events at the Preferred Term (PT) level.</p>2025-08-22T17:25:02ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1371/journal.pone.0330769.t003https://figshare.com/articles/dataset/Signal_detection_results_for_specific_adverse_events_at_the_Preferred_Term_PT_level_/29968747CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/299687472025-08-22T17:25:02Z |
| spellingShingle | Signal detection results for specific adverse events at the Preferred Term (PT) level. Gang Ye (318792) Biotechnology Immunology Cancer Science Policy Space Science Biological Sciences not elsewhere classified severe hypersensitivity reactions reporting odds ratio remained clinically significant proportional reporting ratio concurrent literature review adverse event profile serious adverse events remimazolam &# 8217 detected significant signals serious nature xlink "> study population study aimed strong signal ror ), risk patients risk groups remimazolam demonstrated predominantly elderly novel ultra less pronounced laryngeal edema including cardiac identified signals future research faers database faers data defined period clinical application cardiorespiratory arrest anaphylactic shock acting benzodiazepine |
| status_str | publishedVersion |
| title | Signal detection results for specific adverse events at the Preferred Term (PT) level. |
| title_full | Signal detection results for specific adverse events at the Preferred Term (PT) level. |
| title_fullStr | Signal detection results for specific adverse events at the Preferred Term (PT) level. |
| title_full_unstemmed | Signal detection results for specific adverse events at the Preferred Term (PT) level. |
| title_short | Signal detection results for specific adverse events at the Preferred Term (PT) level. |
| title_sort | Signal detection results for specific adverse events at the Preferred Term (PT) level. |
| topic | Biotechnology Immunology Cancer Science Policy Space Science Biological Sciences not elsewhere classified severe hypersensitivity reactions reporting odds ratio remained clinically significant proportional reporting ratio concurrent literature review adverse event profile serious adverse events remimazolam &# 8217 detected significant signals serious nature xlink "> study population study aimed strong signal ror ), risk patients risk groups remimazolam demonstrated predominantly elderly novel ultra less pronounced laryngeal edema including cardiac identified signals future research faers database faers data defined period clinical application cardiorespiratory arrest anaphylactic shock acting benzodiazepine |